Company: ISRG
Filing Date: 2025-10-22
Form Type: 10-Q
Source: 0001035267-25-000209
Chunk: 62

Company: INTUITIVE SURGICAL INC
Filing Date: 2025-10-22
Form: 10-Q
Item: Item 1
Chunk 62
---
, 2025, compared to $1.26 billion for the three months ended September 30, 2024.

•Systems revenue increased by 33% to $590 million for the three months ended September 30, 2025, compared to $445 million during the three months ended September 30, 2024.

•During the three months ended September 30, 2025, we placed 427 da Vinci surgical systems compared to 379 systems during the three months ended September 30, 2024. The third quarter 2025 da Vinci surgical system placements included 240 da Vinci 5 systems compared to 110 systems in the third quarter of 2024.

•As of September 30, 2025, we had a da Vinci surgical system installed base of approximately 10,763 systems, an increase of 13% compared to an installed base of approximately 9,539 systems as of September 30, 2024.

•Utilization of da Vinci surgical systems, measured in terms of procedures per system per year, increased 4% relative to the third quarter of 2024.

•During the three months ended September 30, 2025, we placed 50 Ion systems compared to 58 systems during the three months ended September 30, 2024.

•As of September 30, 2025, we had an Ion system installed base of approximately 954 systems, an increase of 30% compared to an installed base of approximately 736 systems as of September 30, 2024.

•Gross profit as a percentage of revenue was 66.4% for the three months ended September 30, 2025, compared to 67.4% for the three months ended September 30, 2024.

•Operating income increased by 32% to $760 million for the three months ended September 30, 2025, compared to $577 million during the three months ended September 30, 2024. Operating income included $206 million and $176 million of share-based compensation expense related to employee stock plans and $3.9 million and $3.5 million of intangible asset-related charges for the three months ended September 30, 2025, and 2024, respectively.

•During the three months ended September 30, 2025, we repurchased 4.0 million shares of our common stock for $1.92 billion.

•As of September 30, 2025,